GH
Guardant Health Inc
177.80$
+1.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | 34.9 | 59.6 | 52.9 | 32.3 | 34.2 | 26.8 | 30.2 | 41.0 | 45.0 | 51.8 | 38.8 | 36.9 | 27.2 | 17.2 | 10.1 | 12.8 | 6.2 | 5.0 | 7.6 | 6.5 | 5.7 | 4.2 | 5.5 | 4.1 | 5.1 | 6.8 | 7.8 | 8.7 | 13.4 | 11.2 | 16.7 | |
| – | – | – | – | – | – | – | – | 6.5 | 14.1 | 9.4 | 7.3 | 9.2 | 8.4 | 7.0 | 10.2 | 9.9 | 18.2 | 15.9 | 17.9 | 15.8 | 12.6 | 12.9 | 33.0 | 46.3 | – | 13.3 | 15.3 | 20.2 | 36.7 | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 33.3 | 58.2 | 51.7 | 31.5 | 33.6 | 26.2 | 29.6 | 40.5 | 44.9 | 52.7 | 39.5 | 37.8 | 29.0 | 18.7 | 12.4 | 15.1 | 8.5 | 6.9 | 9.4 | 7.8 | 5.8 | 4.2 | 5.7 | 4.8 | 6.0 | 7.4 | 8.4 | 9.3 | 14.6 | 11.7 | 17.1 | |
| – | – | – | – | – | – | – | – | -2.9% | -1.3% | -1.1% | -1.0% | -0.9% | -1.6% | -1.5% | -1.2% | -1.2% | -0.9% | -1.5% | -2.0% | -2.8% | -4.6% | -8.8% | -7.0% | -13.9% | -17.4% | -9.8% | -10.4% | -10.8% | -12.0% | -8.5% | -9.7% | -7.3% | -5.8% | -4.2% | -3.3% | -1.8% | -2.0% | -1.2% | |
| Margins | |||||||||||||||||||||||||||||||||||||||
| – | – | – | 19.3% | 36.6% | 40.5% | 44.9% | 50.6% | 52.3% | 57.1% | 62.6% | 65.9% | 67.0% | 68.3% | 67.7% | 68.3% | 67.7% | 66.2% | 66.5% | 65.7% | 67.1% | 67.7% | 67.4% | 66.9% | 65.2% | 63.2% | 61.9% | 60.5% | 59.7% | 60.4% | 59.9% | 60.3% | 60.8% | 61.3% | 62.8% | 63.8% | 64.5% | 64.9% | 65.0% | |
| – | – | – | -189.6% | -153.5% | -138.4% | -127.4% | -104.4% | -102.5% | -88.6% | -62.3% | -45.5% | -38.4% | -38.2% | -51.6% | -69.9% | -88.9% | -110.1% | -114.6% | -117.5% | -110.0% | -109.0% | -112.5% | -115.3% | -121.1% | -115.1% | -106.7% | -95.8% | -100.1% | -87.8% | -79.4% | -74.4% | -60.0% | -58.8% | -55.6% | -49.0% | -44.5% | -41.4% | -39.7% | |
| – | – | – | -212.0% | -172.7% | -139.7% | -117.7% | -96.4% | -93.8% | -87.9% | -60.1% | -41.0% | -35.3% | -31.5% | -46.7% | -68.3% | -88.5% | -112.7% | -117.0% | -118.8% | -108.6% | -107.2% | -135.0% | -140.6% | -145.6% | -137.9% | -99.6% | -80.7% | -85.0% | -76.3% | -76.2% | -74.0% | -59.0% | -53.8% | -49.9% | -44.2% | -42.4% | -40.1% | -38.3% | |
| – | – | – | – | -158.1% | -131.8% | -128.9% | -109.4% | -101.9% | -80.3% | -56.0% | -32.8% | -31.9% | -41.7% | -45.9% | -47.5% | -55.1% | -48.0% | -59.2% | -72.4% | -76.0% | -79.1% | -89.0% | -90.0% | -86.1% | -86.6% | -75.1% | -67.8% | -61.3% | -49.8% | -46.5% | -39.6% | -37.2% | -39.4% | -32.8% | -29.1% | -23.7% | -22.0% | -20.3% | |
| Returns | |||||||||||||||||||||||||||||||||||||||
| – | – | – | – | -28.4% | -26.3% | -28.6% | -29.4% | -17.6% | -20.8% | -10.7% | -9.3% | -9.5% | -9.8% | -10.8% | -17.0% | -19.5% | -39.6% | -48.0% | -57.6% | -62.9% | -78.7% | -172.7% | -363.2% | -1,087.7% | – | -173.6% | -189.4% | -302.1% | -675.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | -34.6% | -25.5% | – | -21.8% | -21.8% | -14.5% | -16.8% | -9.3% | -8.0% | -7.9% | -8.2% | -9.4% | -14.7% | -11.2% | -14.3% | -16.5% | -18.4% | -18.4% | -19.7% | -29.7% | -35.6% | -40.7% | -44.0% | -27.6% | -24.1% | -26.8% | -27.0% | -30.5% | -33.3% | -29.4% | -31.0% | -31.1% | -31.2% | -20.7% | -22.6% | -23.7% | |
| Balance Sheet & Debt | |||||||||||||||||||||||||||||||||||||||
| 0.4 | – | – | -72 | -72 | 222 | -111 | -114 | -140 | -154 | -175 | -147 | -136 | -145 | -156 | -136 | -20 | 271 | 202 | 310 | 655 | 578 | 940 | 999 | 1,018 | 938 | 892 | 708 | 34 | 39 | 134 | 481 | 646 | 447 | 513 | 561 | 1,153 | 542 | 477 | |
| 68.4% | – | – | -55.8% | 90.0% | – | 76.3% | 74.1% | 82.3% | 80.8% | 86.8% | 86.0% | 82.9% | 82.8% | 87.2% | 86.5% | 57.2% | 36.1% | 34.4% | 31.9% | 29.3% | 25.0% | 17.2% | 9.8% | 3.7% | -2.9% | 15.9% | 12.7% | 8.9% | 4.0% | -0.1% | -3.9% | -9.4% | -18.7% | -22.9% | -27.8% | -4.9% | -9.5% | -11.7% | |
| 0.4 | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.6 | 1.3 | 1.4 | 1.6 | 1.8 | 2.2 | 3.6 | 6.9 | 19.3 | – | 4.0 | 5.1 | 7.4 | 17.1 | – | – | – | – | – | – | – | – | – | |
| Per Share | |||||||||||||||||||||||||||||||||||||||
| – | – | – | -1.68 | -1.24 | -1.15 | -0.95 | -0.90 | -1.01 | -1.13 | -0.98 | -0.81 | -0.80 | -0.82 | -1.25 | -1.86 | -2.54 | -3.33 | -3.74 | -4.03 | -3.99 | -4.12 | -5.40 | -5.92 | -6.39 | -6.48 | -4.67 | -3.67 | -4.05 | -3.79 | -4.01 | -4.16 | -3.53 | -3.36 | -3.33 | -3.18 | -3.24 | -3.30 | -3.43 | |
| – | – | – | 0.79 | 0.72 | 0.82 | 0.80 | 0.93 | 1.08 | 1.29 | 1.63 | 1.98 | 2.28 | 2.60 | 2.68 | 2.73 | 2.87 | 2.95 | 3.20 | 3.39 | 3.67 | 3.84 | 4.00 | 4.21 | 4.39 | 4.70 | 4.69 | 4.55 | 4.76 | 4.96 | 5.26 | 5.63 | 5.97 | 6.25 | 6.68 | 7.20 | 7.63 | 8.23 | 8.96 | |
| – | 6.03 | – | -2.71 | 4.36 | 4.36 | 3.31 | 3.05 | 5.74 | 5.45 | 9.16 | 8.74 | 8.49 | 8.32 | 11.61 | 10.97 | 12.98 | 8.39 | 7.79 | 6.99 | 6.34 | 5.23 | 3.13 | 1.63 | 0.59 | -0.43 | 2.69 | 1.94 | 1.34 | 0.56 | -0.01 | -0.49 | -1.13 | -2.02 | -2.46 | -2.83 | -0.77 | -1.38 | -1.69 | |
| – | – | – | – | -1.13 | -1.08 | -1.04 | -1.02 | -1.10 | -1.03 | -0.91 | -0.65 | -0.73 | -1.08 | -1.23 | -1.29 | -1.58 | -1.42 | -1.89 | -2.45 | -2.79 | -3.04 | -3.56 | -3.79 | -3.77 | -4.07 | -3.52 | -3.09 | -2.92 | -2.47 | -2.44 | -2.23 | -2.22 | -2.46 | -2.19 | -2.09 | -1.81 | -1.81 | -1.82 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.